Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
Top Cited Papers
Open Access
- 1 September 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (5) , 1565-1573
- https://doi.org/10.1182/blood-2005-02-0516
Abstract
Here we report that a new nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse line harboring a complete null mutation of the common cyKeywords
This publication has 53 references indexed in Scilit:
- Human AML cells in NOD/SCID mice: engraftment potential and gene expressionLeukemia, 2002
- An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/β2-microglobulinnull miceExperimental Hematology, 2002
- Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivoNature Biotechnology, 2002
- Cytokines and immunodeficiency diseasesNature Reviews Immunology, 2001
- The Human Sheep Xenograft Model for the Study of the In Vivo Potential of Human HSC and In Utero Gene TransferThe International Journal of Cell Cloning, 2000
- Homodimerization of IL-2 receptor β chain is necessary and sufficient to activate Jak2 and dowstream signaling pathwaysFEBS Letters, 1998
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-4 ReceptorScience, 1993
- Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-7 ReceptorScience, 1993
- Cloning of the γ Chain of the Human IL-2 ReceptorScience, 1992